$OSRH News

OSR Holdings Inks Deal To Acquire Full Global Intellectual Property Portfolio, Related Assets Of VAXIMM For $30M

OSR Holdings Q1 EPS $(0.09) Beats $(0.29) Estimate, Sales $484.057K Miss $778.000K Estimate

OSR Holdings Says It Will Not Pursue Reverse Stock Split; Plans To Regain Nasdaq Compliance Through Organic Growth And Business Milestones

OSR Holdings Stock Surges Over 41% After Hours: Why Is It Moving?

OSR Holdings shares are trading lower after the company announced a license agreement for its VXM01 immunotherapy that includes up to $815 million in milestone payments.

OSR Holdings Enters Into A Definitive Global Exclusive License Agreement With BCM Europe AG For The Development, Commercialization, And Potential Sublicensing Of VXM01; OSRH To Receive Up To $815M In Milestone Payments Tied To Clinical, Regulatory, And Commercial Achievements

OSR Holdings Eliminates $2.02M Warrant Overhang; Issues $555K Convertible Note At $1 Premium Share Price

OSR Holdings Signs Revised Global Licensing Deal For VXM01; BCME To Pay Up To $815M In Milestone Payments To OSR Holdings; To Provide Vaximm With Up To $30M Development Financing Facility

OSR Holdings Q4 EPS $(0.16) Misses $(0.10) Estimate, Sales $381.269K Miss $761.000K Estimate

OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level

OSR Holdings Restructures VXM01 Licensing Deal To Capture Up To $815M In Milestones At Parent Level And Boost Capital Efficiency

Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials

Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities

OSR Holdings' Woori IO Enters Into Mutual NDA With Sinopharm Group To Explore China Commercial Opportunities

OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum

12 Health Care Stocks Moving In Thursday's Intraday Session

OSR Holdings shares are trading higher after the company was granted an additional 180-day extension to regain compliance with Nasdaq.

OSR Holdings Receives Written Notification From The Nasdaq Granting The Company An Additional 180-Calendar-Day Extension To Regain Compliance